123 related articles for article (PubMed ID: 33772882)
1. Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma.
Okabe M; Morishita T; Yasuda T; Sakaguchi H; Sanada M; Kataoka K; Ogawa S; Shiraishi Y; Ichiki T; Kawaguchi Y; Ohbiki M; Matsumoto R; Osaki M; Goto T; Ozawa Y; Miyamura K
Eur J Haematol; 2021 Jul; 107(1):166-169. PubMed ID: 33772882
[No Abstract] [Full Text] [Related]
2. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
[TBL] [Abstract][Full Text] [Related]
3. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
5. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
[TBL] [Abstract][Full Text] [Related]
6. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
[TBL] [Abstract][Full Text] [Related]
7. Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay.
Blombery PA; Ryland GL; Markham J; Guinto J; Wall M; McBean M; Jones K; Thompson ER; Cameron DL; Papenfuss AT; Prince MH; Dickinson M; Westerman DA
Br J Haematol; 2018 Oct; 183(1):146-149. PubMed ID: 28880377
[No Abstract] [Full Text] [Related]
8. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutation panels: Time to clear their names.
Trottier AM; Cavalcante de Andrade Silva M; Li Z; Godley LA
Cancer Genet; 2019 Jun; 235-236():84-92. PubMed ID: 31101556
[TBL] [Abstract][Full Text] [Related]
10. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
Hauke J; Hahnen E; Schneider S; Reuss A; Richters L; Kommoss S; Heimbach A; Marmé F; Schmidt S; Prieske K; Gevensleben H; Burges A; Borde J; De Gregorio N; Nürnberg P; El-Balat A; Thiele H; Hilpert F; Altmüller J; Meier W; Dietrich D; Kimmig R; Schoemig-Markiefka B; Kast K; Braicu E; Baumann K; Jackisch C; Park-Simon TW; Ernst C; Hanker L; Pfisterer J; Schnelzer A; du Bois A; Schmutzler RK; Harter P
J Med Genet; 2019 Sep; 56(9):574-580. PubMed ID: 30979843
[TBL] [Abstract][Full Text] [Related]
11. Deep sequencing of atrial fibrillation patients with mitral valve regurgitation shows no evidence of mosaicism but reveals novel rare germline variants.
Gregers E; Ahlberg G; Christensen T; Jabbari J; Larsen KO; Herfelt CB; Henningsen KM; Andreasen L; Thiis JJ; Lund J; Holme S; Haunsø S; Bentzen BH; Schmitt N; Svendsen JH; Olesen MS
Heart Rhythm; 2017 Oct; 14(10):1531-1538. PubMed ID: 28549997
[TBL] [Abstract][Full Text] [Related]
12. A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1.
Cianci P; Tono V; Sala A; Locatelli L; Carta C; Rizzari C; Biondi A; Selicorni A
Am J Med Genet A; 2013 Jun; 161A(6):1401-4. PubMed ID: 23613113
[TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma.
Ben Aim L; Pigny P; Castro-Vega LJ; Buffet A; Amar L; Bertherat J; Drui D; Guilhem I; Baudin E; Lussey-Lepoutre C; Corsini C; Chabrier G; Briet C; Faivre L; Cardot-Bauters C; Favier J; Gimenez-Roqueplo AP; Burnichon N
J Med Genet; 2019 Aug; 56(8):513-520. PubMed ID: 30877234
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing.
Connor AA; Katzov-Eckert H; Whelan T; Aronson M; Lau L; Marshall C; Charames GS; Pollett A; Gallinger S; Lerner-Ellis J
Fam Cancer; 2015 Mar; 14(1):69-75. PubMed ID: 25380764
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
McNulty SN; Parikh BA; Duncavage EJ; Heusel JW; Pfeifer JD
J Mol Diagn; 2019 Sep; 21(5):903-912. PubMed ID: 31251990
[TBL] [Abstract][Full Text] [Related]
16. Germline Variation and Somatic Alterations in Ewing Sarcoma.
Machiela MJ; Grünewald TGP
Methods Mol Biol; 2021; 2226():3-14. PubMed ID: 33326089
[TBL] [Abstract][Full Text] [Related]
17. Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing.
Kreck B; Richter J; Ammerpohl O; Barann M; Esser D; Petersen BS; Vater I; Murga Penas EM; Bormann Chung CA; Seisenberger S; Lee Boyd V; Smallwood S; Drexler HG; Macleod RA; Hummel M; Krueger F; Häsler R; Schreiber S; Rosenstiel P; Franke A; Siebert R
Leukemia; 2013 Aug; 27(8):1751-3. PubMed ID: 23307032
[No Abstract] [Full Text] [Related]
18. The contribution of next generation sequencing to epilepsy genetics.
Møller RS; Dahl HA; Helbig I
Expert Rev Mol Diagn; 2015; 15(12):1531-8. PubMed ID: 26565596
[TBL] [Abstract][Full Text] [Related]
19. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.
Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK
Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441
[TBL] [Abstract][Full Text] [Related]
20. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
